Kidney Disease Clinical Trials

Showing 1841-1860 of 3,902 trials

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

NCT01381094

The purpose of this study is to evaluate the dose response (efficacy), pharmacodynamic response, pharmacokinetics, safety, and tolerability of orally administered AKB-6548 in pre-dialysis participants with anemia with repeat dosing for 42 days.

AnemiaKidney Disease

Akebia Therapeutics93 participantsStarted Jun 2011

Pine Bluff, Arkansas, United States • Covina, California, United States • Los Angeles, California, United States +25 more locations

COMPLETEDPhase 1

A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

NCT05012436

The purpose of this trial is to compare the pharmacokinetic characteristics and safety of YHD1119(Pregabalin SR 75mg) and YHD1119(Pregabalin SR 150mg) in subjects with renal impairment and healthy subjects. YHD1119 is sustained-release (SR) formulation which is made by Yuhan Corporation. Primary endpoints are Cmax and AUClast and secondary endpoints are AUCinf,Tmax, t1/2, CL/F and V/F.

Healthy VolunteerRenal Impairments

Yuhan Corporation16 participantsStarted Jul 2021

Gyeonggi-do, South Korea • Seoul, South Korea

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

Related Searches

Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study)

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis

Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis

Food Effect Study of DDO-3055 Tablets in Healthy Subjects

End-Stage Kidney Disease Interactive Decision Aid for the Elderly (myKIDNEY)

Outcome of Glargine Insulin in Renal Impairment Patients With Diabetic Ketoacidosis

The Effect of Food Intake During Hemodialysis on Blood Pressure

Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101

Normotonic Partial Nephrectomy as Novel Approach in Treating Small Renal Masses

Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis

Association of Long-term Conditions With Survival Following Heart Attack in England and Wales

Treatment of Obstructive Sleep Apnea in Chronic Kidney Disease